BIOLASE Technology, Inc. (BIOLASE), a dental devices company, has promoted its chief financial officer (CFO) David M. Mulder to the company as new chief executive officer (CEO), effective March 5, 2009. Mulder succeeds Jake St. Philip, who has resigned his positions as CEO and director of the company to pursue other interests. Earlier, Mulder, served for two years as the CFO and chief operating officer of American LaFrance.
From 2002 through 2005, Mulder served as the executive vice president, chief administrative officer, and senior financial officer of Salton, Inc. He spent six years with Fruit of the Loom, in progressive financial and operational roles, culminating as the head of the European business in 2000. For his efforts in controlling costs and driving profitability at BIOLASE in the first half of 2008, he was recently nominated to be a candidate for CFO of the year in the Orange County Business Journal’s annual program to recognize the leading chief financial officers in Orange County.
Mulder began his professional career in accounting and consulting with Arthur Anderson, and holds an MBA from Duke University, Fuqua School of Business.
BIOLASE chairman of the board George V. d’Arbeloff said, “We are fortunate to have someone with Dave’s extensive domestic and international financial and operational background to take over the role of CEO at this pivotal time in the Company’s history. He will be able to hit the ground running as he has been a key part of the BIOLASE senior management team working closely with the Board and the entire organization since joining the Company in April of last year. Dave has led our efforts to realign and reduce the Company’s cost structure, played a key role in the implementation of the reorganization of our domestic and international organizations, participated in new product development programs, and was instrumental in helping the Company reach profitability for the first half of 2008. And, most recently, he was instrumental in establishing our new purchase agreement with Henry Schein.”
“We would also like to thank Jake for his service as the Company’s Chief Executive Officer, and wish him all the best in this new phase of his professional career,” d’Arbeloff added.
BIOLASE CEO Dave Mulder said, “I appreciate the confidence of the Board in asking me to serve as CEO. I look forward to continuing to work with the Board and the management team of BIOLASE. I am particularly thankful for the ongoing help of Federico Pignatelli, our President, during the development of the recently announced Henry Schein agreement and for his support in the management transition process.”